Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

February 1, 2017

Biogen Completes Separation of Global Hemophilia Business, Bioverativ

January 26, 2017

Biogen Reports 2016 Revenues of $11.4 Billion

January 17, 2017

Biogen Fourth Quarter and Year End 2016 Financial Results Webcast Adjusted to 8:00 am on January 26, 2017

January 17, 2017

Siemens Healthineers and Biogen Announce Agreement to Jointly Develop New MRI Tools for Multiple Sclerosis

January 17, 2017

Biogen and Forward Pharma Agree to Enter into Settlement and License Agreement

January 13, 2017

New Data Show SPINRAZA™ (nusinersen) Significantly Reduces Risk of Death or Permanent Ventilation in Infantile-Onset Spinal Muscular Atrophy

January 12, 2017

Biogen Spin-off Bioverativ Commences When-Issued Trading of Common Stock

December 23, 2016

U.S. FDA Approves Biogen’s SPINRAZA™ (nusinersen), The First Treatment for Spinal Muscular Atrophy

December 22, 2016

Biogen Announces Effectiveness of Bioverativ Form 10 Registration Statement

December 22, 2016

Biogen Announces that Bioverativ will Host an Investor Day on January 6, 2017

Pagination

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page

Displaying 121 - 130 of 652

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us